SEC Form 4 · accession 0001209191-19-007373
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey M. Curtis
Officer — EVP, Corporate Affairs, CCO
Period of report
Feb 5, 2019
Accepted (ET)
Feb 5, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Feb 5, 2019 | S | 5,500 | $23.1067 | D | 32,202 | D | |
| Ordinary Shares | Feb 5, 2019 | S | 2,000 | $23.25 | D | 30,202 | D | |
| Ordinary Shares | Feb 5, 2019 | S | 1,335 | $23.20 | D | 28,867 | D | |
| Ordinary Shares | holding | — | — | — | 420 | I | By spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on December 13, 2018.